Buy Cyclacel Pharmaceuticals Stock | CYCC Stock Price & Latest News | Public.com
CYCC

Cyclacel Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View Cyclacel Pharmaceuticals (CYCC) stock trends here

    About CYCC

    Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.45
    -0.89
    -1.34
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.53

    Actual EPS
    Q1 2021

    Stats

    Market Cap$36,91M
    Volume261,64k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$19.25
    1 Year Low$3.12
    Open$7.13
    High$7.13
    Low$6.45

    Buy any stock with any amount of money.

    Download the App
    Download the app